Generated: December 11, 2017
DrugPatentWatch Database Preview
Ciprofloxacin; dexamethasone - Generic Drug Details
« Back to Dashboard
What are the generic drug sources for ciprofloxacin; dexamethasone and what is the scope of ciprofloxacin; dexamethasone patent protection?
is the generic ingredient in one branded drug marketed by Novartis Pharms Corp and is included in one NDA. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
Ciprofloxacin; dexamethasone has forty-three patent family members in twenty-two countries and three supplementary protection certificates in three countries.
There are thirty-one drug master file entries for ciprofloxacin; dexamethasone. Four suppliers are listed for this compound.
Summary for ciprofloxacin; dexamethasone
Pharmacology for ciprofloxacin; dexamethasone
Expired Orange Book Patents for Generic Ingredient: ciprofloxacin; dexamethasone
International Patent Family for Ingredient: ciprofloxacin; dexamethasone
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Supplementary Protection Certificates for Tradename: CIPROFLOXACIN; DEXAMETHASONE
|Supplementary Protection Certificate
| 2012 00045||Denmark||► Subscribe|
|C/GB12/058||United Kingdom||► Subscribe||PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003|
|C0012||France||► Subscribe||PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.